Inventor · disambiguated record
Young Gil Ahn
Also filed as: AHN YOUNG GIL
25 granted patents·7 pending applications·66 citations·filing 2004–2023
94Inventor score
Files withHANMI PHARM IND CO LTD12HANMI PHARMACEUTICAL CO LTD10KOREA INST SCI & TECH2AHN YOUNG-GIL1BAE IN HWAN1
Top patents by PatentIndex Score
32 records- 0193US11292786B2Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameHANMI PHARM IND CO LTD·Filed 2020·Granted Apr 5, 2022·4 cites·7 claims
- 0287US11535629B2Dioxoloisoquinolinone derivatives and use thereofHANMI PHARMACEUTICAL CO LTD·Filed 2021·Granted Dec 27, 2022·2 cites·15 claims
- 0387US10280154B2Pyrimidine compound and pharmaceutical use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted May 7, 2019·4 cites·18 claims
- 0485US10519141B2Pyrimidine compound and pharmaceutical use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted Dec 31, 2019·3 cites·11 claims
- 0584US10870639B2Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameHANMI PHARM IND CO LTD·Filed 2019·Granted Dec 22, 2020·3 cites·6 claims
- 0681US8940908B2Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in sameHANMI SCIENCE CO LTD·Filed 2014·Granted Jan 27, 2015·4 cites·5 claims
- 0780US8188102B2Amide derivative for inhibiting the growth of cancer cellsLEE KWANG-OK·Filed 2008·Granted May 29, 2012·15 cites·4 claims
- 0879US9388165B2Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinaseHANMI PHARM IND CO LTD·Filed 2013·Granted Jul 12, 2016·6 cites·13 claims
- 0976US12325698B2Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameHANMI PHARMACEUTICAL CO LTD·Filed 2022·Granted Jun 10, 2025·0 cites·8 claims
- 1076US7625926B2P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the sameHANMI PHARM IND CO LTD·Filed 2004·Granted Dec 1, 2009·9 cites·9 claims
- 1174US9156852B2Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinasesHANMI PHARM IND CO LTD·Filed 2012·Granted Oct 13, 2015·3 cites·14 claims
- 1274US8680277B2Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in sameBANG KEUK CHAN·Filed 2011·Granted Mar 25, 2014·4 cites·17 claims
- 1370US10696675B2Imidazopyridopyrimidine derivative compound and use thereofHANMI PHARMACEUTICAL CO LTD·Filed 2017·Granted Jun 30, 2020·1 cites·12 claims
- 1467USRE47451EThieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinasesHANMI PHARM IND CO LTD·Filed 2012·Granted Jun 25, 2019·1 cites·63 claims
- 1567US2023060973A1Thieno[3,2-d]pyrimidine derivative compound having inhibitory activity for protein kinaseHANMI PHARM IND CO LTD·Filed 2022·Application pending·0 cites
- 1666US8999973B2Thieno[3,2-d]pyrimidine derivatives having inhibitory activity on protein kinasesSON JUNG BEOM·Filed 2011·Granted Apr 7, 2015·2 cites·14 claims
- 1765US8835458B2Quinoline or quinazoline derivatives with apoptosis inducing activity on cellsBAE IN HWAN·Filed 2011·Granted Sep 16, 2014·3 cites·14 claims
- 1864US11492357B2Thieno[3,2-d]pyrimidine derivative compound having inhibitory activity for protein kinaseHANMI PHARM IND CO LTD·Filed 2018·Granted Nov 8, 2022·0 cites·9 claims
- 1964US2025353831A1Novel heterobicyclic compound for inhibiting yap-tead interaction and pharmaceutical composition comprising sameHANMI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 2061US8846699B2Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereofAHN YOUNG-GIL·Filed 2006·Granted Sep 30, 2014·1 cites·3 claims
- 2161US2024423979A1Therapeutically effective combination of a flt3 inhibitor and a bcl-2 inhibitor for the treatment of acute myeloid leukemiaHANMI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2257US10112954B2Bicyclic heteroaryl derivatives having inhibitory activity for protein kinaseJUNG SEUNG HYUN·Filed 2011·Granted Oct 30, 2018·1 cites·7 claims
- 2355US2024067613A1Novel quinazoline derivatives as sos1 inhibitors and use thereofHANMI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2453US2024173329A1Belvarafenib for use in treatment of brain cancersGENENTECH INC·Filed 2022·Application pending·0 cites
- 2550US12350265B2Pharmaceutical composition for treating acute myeloid leukemia, containing FLT3 inhibitor and chemotherapeutic agentsHANMI PHARMACEUTICAL CO LTD·Filed 2020·Granted Jul 8, 2025·0 cites·21 claims
- 2649US2011124888A1Styrylbenzofuran derivatives as inhibitors for beta-amyloid fibril formation and preparation method thereofKOREA INST SCI & TECH·Filed 2009·Application pending·0 cites
- 2748US12433867B2Pharmaceutical composition comprising FLT3 inhibitor and hypomethylating agent for treating acute myeloid leukemiaHANMI PHARMACEUTICAL CO LTD·Filed 2020·Granted Oct 7, 2025·0 cites·11 claims
- 2847US12479845B2Imidazopyridine derivative compounds and use of sameHANMI PHARMACEUTICAL CO LTD·Filed 2020·Granted Nov 25, 2025·0 cites·11 claims
- 2946US12344618B2Heterotricyclic derivative compound and use of sameHANMI PHARMACEUTICAL CO LTD·Filed 2020·Granted Jul 1, 2025·0 cites·12 claims
- 3046US11254676B2Pyrazole derivative compound and use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted Feb 22, 2022·0 cites·6 claims
- 3145US11649246B2Salts of 4-amino-N-(l-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-D]pyrimidine-7-carboxamide, and crystalline forms thereofHANMI PHARM IND CO LTD·Filed 2018·Granted May 16, 2023·0 cites·19 claims
- 3243US2015065494A1Aminostyrylbenzofuran derivatives as inhibitors against beta-amyloid fibril formation, and pharmaceutical composition comprising sameKOREA INST SCI & TECH·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Young Gil Ahn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →